These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 8409044

  • 21. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ.
    Circulation; 1996 Nov 15; 94(10):2389-95. PubMed ID: 8921778
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
    Zhang B, Wieslander JB.
    Microsurgery; 1996 Nov 15; 17(2):89-96. PubMed ID: 8914063
    [Abstract] [Full Text] [Related]

  • 23. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G, Renga C, Weitz JI, Nenci GG, Hirsh J.
    Blood; 1992 Aug 15; 80(4):960-5. PubMed ID: 1498336
    [Abstract] [Full Text] [Related]

  • 24. A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.
    Schenk JF, Glusa E, Radziwon P, Butti A, Markwardt F, Breddin HK.
    Haemostasis; 1996 Aug 15; 26(4):187-94. PubMed ID: 8872129
    [Abstract] [Full Text] [Related]

  • 25. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 12; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
    Freund M, Cazenave JP, Courtney M, Degryse E, Roitsch C, Bernat A, Delebassée D, Defreyn G, Maffrand JP.
    Thromb Haemost; 1990 Apr 12; 63(2):187-92. PubMed ID: 2363120
    [Abstract] [Full Text] [Related]

  • 32. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep 12; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
    Bossavy JP, Sakariassen KS, Rübsamen K, Thalamas C, Boneu B, Cadroy Y.
    Arterioscler Thromb Vasc Biol; 1999 May 12; 19(5):1348-53. PubMed ID: 10323789
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS, Zoldhelyi P, Webster MW, Heras M, Grill DE, Holmes DR, Fuster V, Chesebro JH.
    Circulation; 1996 Feb 15; 93(4):792-9. PubMed ID: 8641009
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.